# Senate Bill 5507

[Source](http://lawfilesext.leg.wa.gov/biennium/2021-22/Pdf/Bills/Senate%20Bills/5507.pdf)
## Section 1
> This section modifies existing section [18.64.257](/rcw/18_businesses_and_professions/18.064_pharmacists.md). Here is the [modified chapter](rcw/18_businesses_and_professions/18.064_pharmacists.md) for context.

This chapter shall not prevent a medicare-approved dialysis center or facility operating a medicare-approved home dialysis program**, or a manufacturer of commercially available dialysate and dialysis devices used by home dialysis patients, or a manufacturer's agent acting on behalf of such manufacturer,** from selling, delivering, possessing, or dispensing directly to its dialysis patients,  if prescribed by a physician licensed under chapter 18.57 or 18.71 RCW, **dialysis devices and** those legend drugs**, in case or full shelf lots,** determined by the commission pursuant to rule.


## Section 2
> This section modifies existing section [69.41.032](/rcw/69_food_drugs_cosmetics_and_poisons/69.41_legend_drugs—prescription_drugs.md). Here is the [modified chapter](rcw/69_food_drugs_cosmetics_and_poisons/69.41_legend_drugs—prescription_drugs.md) for context.

This chapter shall not prevent a medicare-approved dialysis center or facility operating a medicare-approved home dialysis program**, or a manufacturer of commercially available dialysate used by home dialysis patients, or a manufacturer's agent acting on behalf of such manufacturer,** from selling, delivering, possessing, or dispensing directly to its dialysis patients, in case or full shelf lots, if prescribed by a physician licensed under chapter 18.57 or 18.71 RCW, those legend drugs determined by the commission pursuant to rule.

